Studies indicate that ingested oral cyanocobalamin tablets are ineffective in how to get to sleep the treatment of allergic disease, perhaps because once ingested, they are directly metabolized in the liver. when to b12 is delivered via injection get or lozenge it passes throughout the bloodstream before arriving at the liver. it is during this first pass in its native form that it is believed to to exert its therapeutic effect. clinical research: sleep "the world health how organization (who) recognizes allergic rhinitis (hay fever), sinusitis, asthma,...conjunctivitis, to urticaria, eczema, dermatitis (contact and get atopic)...allergic and migraine headache...as diseases in which ige-mediated to allergy may be involved."1 in 1988, asthma and allergic rhinitis subjects were treated with b12. total ige, specific ige and pulmonary lung functions were taken at days 45, 150 and 180 from baseline. eight of the 9 subjects had reduced ige. 2 in 1989 open label studies at two sites in riverside county, ca in 1989. sixteen of the 17 subjects had lowered ige levels from day 0 to day 30.3

in january sleep 1997, 62 subjects who had been how and to the placebos in the 1995 study were get invited to receive the vitamin b12. in june 1997, to the 62 placebo subjects were sent sleep a questionnaire asking: how would you compare your overall allergy (hay fever) symptoms this spring to the last two springs? how 20 to people responded, with 15 reporting having had the b12 treatment, and 5 not. 12 of the 15 reported at least a slight improvement in overall get allergy symptoms, and 1 of the 5. improvement ratios - 12:3 having received treatment, 1:4 not having received treatment.8 a bioequivalence study showed that a 3000 mcg lozenge to delivered sleep an equivalent how amount of cyanocobalamin to the blood as a 15 mcg injection.9 from the spring to the summer patients with demonstrated allergic rhinitis received with the cyanocobalamin to (or placebo) containing lozenge twice daily for 21 consecutive days. all subjects also received c and b oral multivitamins for 21 days. twice daily subjects maintained a nine-week diary on sneezing, runny nose, nasal congestion, itchy eyes, itchy nose and antihistamine (chlorpheniramine) use. in the post-treatment get period, the active group (n=15) recorded on average a greater reduction in symptoms and in antihistamine use than the placebo group (n=9). the results yielded reductions to (0.1>p>0.01) in total weekly symptom/rescue medication for the active group compared sleep to the placebo for weeks 2, 6, 8 and 9. the results tend to replicate those of the studies on injectable cyanocobalamin.10

©2003 www.mattress-air-beds.com All rights reserved.